- Home
- ETON vs NL Comparison
ETON vs NL Comparison
Compare ETON & NL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- NL
- Stock Information
- Founded
- ETON 2017
- NL 1891
- Country
- ETON United States
- NL United States
- Employees
- ETON N/A
- NL N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- NL Major Chemicals
- Sector
- ETON Health Care
- NL Industrials
- Exchange
- ETON Nasdaq
- NL Nasdaq
- Market Cap
- ETON 329.8M
- NL 342.9M
- IPO Year
- ETON 2018
- NL N/A
- Fundamental
- Price
- ETON $14.51
- NL $6.98
- Analyst Decision
- ETON Strong Buy
- NL Sell
- Analyst Count
- ETON 3
- NL 1
- Target Price
- ETON $24.00
- NL $6.00
- AVG Volume (30 Days)
- ETON 330.6K
- NL 32.6K
- Earning Date
- ETON 03-13-2025
- NL 03-05-2025
- Dividend Yield
- ETON N/A
- NL 4.61%
- EPS Growth
- ETON N/A
- NL N/A
- EPS
- ETON N/A
- NL 1.19
- Revenue
- ETON $34,677,000.00
- NL $150,690,000.00
- Revenue This Year
- ETON $22.19
- NL $2.18
- Revenue Next Year
- ETON $110.87
- NL $2.50
- P/E Ratio
- ETON N/A
- NL $5.82
- Revenue Growth
- ETON 5.64
- NL N/A
- 52 Week Low
- ETON $3.03
- NL $5.00
- 52 Week High
- ETON $18.41
- NL $9.42
- Technical
- Relative Strength Index (RSI)
- ETON 41.72
- NL 40.22
- Support Level
- ETON $14.18
- NL $6.85
- Resistance Level
- ETON $17.13
- NL $7.37
- Average True Range (ATR)
- ETON 1.03
- NL 0.31
- MACD
- ETON -0.50
- NL -0.01
- Stochastic Oscillator
- ETON 7.80
- NL 20.73
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About NL NL Industries Inc.
NL Industries Inc operates in the component products industry through its majority-owned subsidiary, CompX International Inc. It manufactures engineered components that are sold to a range of industries, including recreational transportation, postal, office and institutional furniture, cabinetry, tool storage, healthcare, gas stations and vending equipment. CompX has three production facilities in the United States, through which it produces a precision ball bearing slide, security products, and ergonomic computer support systems. The company derives majority of its revenue from Europe.